Percutaneous Transluminal Angioplasty (PTA) Balloons Market: By Product Type (Drug Eluting Balloons, Normal Balloons, Scoring Balloons, Cutting Balloons), By Application (Peripheral Artery Disease, Coronary Artery Disease), By End Users (Hospitals, Clinics, Ambulatory Surgical Centers), and By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Percutaneous Transluminal Angioplasty (PTA) Balloons Market is expected to grow at a CAGR of 4% during the forecast period 2023 to 2029. Percutaneous transluminal angioplasty (PTA) is a process carried to treat the peripheral artery disease (PAD) by open up the arteries that are narrowed by plaque. Percutaneous transluminal angioplasty (PTA) is a procedure in which a small flexible catheter with a diameter of only a few millimetres is introduced into an artery and guided to a desired site where the blood vessel has narrowed due to cardiovascular disease. A tiny balloon is inflated at the end of the catheter when it reaches the target place, squeezing the blocking component responsible for the restricted artery against the blood vessel wall and restoring normal blood flow. When the balloon is inflated, the blood vessel opening widens, allowing more blood to flow to the heart. During the procedure, a stent is frequently used to maintain the artery open after the balloon is deflated and removed. Superior technological advancements such as progressive flexibility due to innovations in hydrophilic design, superior hydrophilic coatings, improved performance under high pressure due to added pushability, and robust design reducing friction are expected to drive the global percutaneous transluminal angioplasty balloons market growth during the forecast period. Rising reimbursement coverage for the treatment of cardiac diseases, especially among end-users in developing countries (which have a relatively higher patient population), are some of the factors likely to drive the growth of the global percutaneous transluminal angioplasty balloons market between 2017 and 2025. However, the risk of patient discomfort during balloon inflation and the possibility of restenosis are two factors that are anticipated to limit the worldwide Percutaneous Transluminal Angioplasty (PTA) Balloons Market growth over the forecast period.

Percutaneous Transluminal Angioplasty Pta Balloons Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4%

Largest Market

North America

Fastest Growing Market

Europe
Percutaneous Transluminal Angioplasty (PTA) Balloons Market Dynamics

Increase in the prevalence of peripheral or coronary artery diseases, development in imaging technologies, recent launch of several percutaneous transluminal angioplasty balloons, and rise in R&D for the manufacturing of advanced technology balloons such as drug-eluting balloons are anticipated to fuel the percutanleous transluminal angioplasty balloons market over the forecast period. However, stringent guidelines for product approval, high cost of PTA balloons, and lack of awareness about advanced PTA balloons in underdeveloped countries may restrain the growth of percutaneous transluminal angioplasty balloons market.

Key Features of the Reports

  • The percutaneous transluminal angioplasty (PTA) balloons market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Percutaneous Transluminal Angioplasty Pta Balloons Market Segmentation

Product Type
  • Drug-Eluting Balloons
  • Normal Balloons
  • Scoring Balloons
  • Cutting Balloons
By Application
  • Peripheral Artery Disease
  • Coronary Artery Disease
By End User
  • Hospitals
  • Cardiology Clinics
  • Ambulatory Surgical Centers

Frequently Asked Questions

The key segments covered in the Percutaneous Transluminal Angioplasty (PTA) Balloons Market are: by product type, by application and by end users

The Percutaneous Transluminal Angioplasty (PTA) Balloons Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Europe is the fastest-growing for Percutaneous Transluminal Angioplasty (PTA) Balloons Market

1.Executive Summary
2.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Introduction 
2.1.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market  - Taxonomy
2.2.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.End User
2.2.4.Route of Administration
2.2.5.Region
3.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Drug-Eluting Balloons
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Normal Balloons
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Scoring Balloons
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Cutting Balloons
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Peripheral Artery Disease
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Coronary Artery Disease
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cardiology Clinics
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market  By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Injection
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Nasal Spray
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Drug-Eluting Balloons
10.1.2.Normal Balloons
10.1.3.Scoring Balloons
10.1.4.Cutting Balloons
10.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Peripheral Artery Disease
10.2.2.Coronary Artery Disease
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Cardiology Clinics
10.3.3.Ambulatory Surgical Centers
10.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Injection
10.4.2.Nasal Spray
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Drug-Eluting Balloons
11.1.2.Normal Balloons
11.1.3.Scoring Balloons
11.1.4.Cutting Balloons
11.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Peripheral Artery Disease
11.2.2.Coronary Artery Disease
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Cardiology Clinics
11.3.3.Ambulatory Surgical Centers
11.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Injection
11.4.2.Nasal Spray
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Drug-Eluting Balloons
12.1.2.Normal Balloons
12.1.3.Scoring Balloons
12.1.4.Cutting Balloons
12.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Peripheral Artery Disease
12.2.2.Coronary Artery Disease
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Cardiology Clinics
12.3.3.Ambulatory Surgical Centers
12.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Injection
12.4.2.Nasal Spray
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Drug-Eluting Balloons
13.1.2.Normal Balloons
13.1.3.Scoring Balloons
13.1.4.Cutting Balloons
13.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Peripheral Artery Disease
13.2.2.Coronary Artery Disease
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Cardiology Clinics
13.3.3.Ambulatory Surgical Centers
13.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Injection
13.4.2.Nasal Spray
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Drug-Eluting Balloons
14.1.2.Normal Balloons
14.1.3.Scoring Balloons
14.1.4.Cutting Balloons
14.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Peripheral Artery Disease
14.2.2.Coronary Artery Disease
14.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospitals
14.3.2.Cardiology Clinics
14.3.3.Ambulatory Surgical Centers
14.4.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Injection
14.4.2.Nasal Spray
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.R. Bard, Inc. (U.S.)
15.2.2.Cook Medical, Inc. (U.S.)
15.2.3.Abbott, Inc. (U.S.)
15.2.4.Cardinal Health, Inc. (U.S.)
15.2.5.Boston Scientific Corporation (U.S.)
15.2.6.Spectranetics Corporation (Philips Holding USA Inc.) (U.S.)
15.2.7.Medtronic Plc (Ireland)
15.2.8.SurModics Inc. (U.S.)
15.2.9.ENDOCOR GmbH (Germany)
16. Research Methodology 
17. Appendix and Abbreviations 

 

  • R. Bard, Inc. (U.S.)
  • Cook Medical, Inc. (U.S.)
  • Abbott, Inc. (U.S.)
  • Cardinal Health, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Spectranetics Corporation (Philips Holding USA Inc.) (U.S.)
  • Medtronic Plc (Ireland)
  • SurModics Inc. (U.S.)
  • ENDOCOR GmbH (Germany)

Adjacent Markets